143 related articles for article (PubMed ID: 16162182)
1. Humoral immunity to vimentin is associated with cardiac allograft injury in nonhuman primates.
Azimzadeh AM; Pfeiffer S; Wu GS; Schröder C; Zhou H; Zorn GL; Kehry M; Miller GG; Rose ML; Pierson RN
Am J Transplant; 2005 Oct; 5(10):2349-59. PubMed ID: 16162182
[TBL] [Abstract][Full Text] [Related]
2. Alloimmunity in primate heart recipients with CD154 blockade: evidence for alternative costimulation mechanisms.
Azimzadeh AM; Pfeiffer S; Wu G; Schröder C; Zorn GL; Kelishadi SS; Ozkaynak E; Kehry M; Atkinson JB; Miller GG; Pierson RN
Transplantation; 2006 Jan; 81(2):255-64. PubMed ID: 16436970
[TBL] [Abstract][Full Text] [Related]
3. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A
Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995
[TBL] [Abstract][Full Text] [Related]
4. C4d deposition is correlated with the level of antivimentin antibody in rat kidneys undergoing chronic allograft nephropathy.
Yang L; Lu YP; Luo GH; Song J; Tu ZD; Li YP
Transplant Proc; 2008 Oct; 40(8):2786-9. PubMed ID: 18929862
[TBL] [Abstract][Full Text] [Related]
5. The autoimmune response to vimentin after renal transplantation in nonhuman primates is immunosuppression dependent.
Jonker M; Danskine A; Haanstra K; Wubben J; Kondova I; Kuhn EM; Rose M
Transplantation; 2005 Aug; 80(3):385-93. PubMed ID: 16082335
[TBL] [Abstract][Full Text] [Related]
6. Comparative Evaluation of αCD40 (2C10R4) and αCD154 (5C8H1 and IDEC-131) in a Nonhuman Primate Cardiac Allotransplant Model.
OʼNeill NA; Zhang T; Braileanu G; Sun W; Cheng X; Hershfeld A; Laird CT; Kronfli A; Hock LA; Dahi S; Kubicki N; Sievert E; Hassanein W; Cimeno A; Pierson RN; Azimzadeh AM
Transplantation; 2017 Sep; 101(9):2038-2047. PubMed ID: 28557955
[TBL] [Abstract][Full Text] [Related]
7. Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys.
Kelishadi SS; Azimzadeh AM; Zhang T; Stoddard T; Welty E; Avon C; Higuchi M; Laaris A; Cheng XF; McMahon C; Pierson RN
J Clin Invest; 2010 Apr; 120(4):1275-84. PubMed ID: 20335656
[TBL] [Abstract][Full Text] [Related]
8. Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates.
Elster EA; Xu H; Tadaki DK; Montgomery S; Burkly LC; Berning JD; Baumgartner RE; Cruzata F; Marx R; Harlan DM; Kirk AD
Transplantation; 2001 Nov; 72(9):1473-8. PubMed ID: 11707732
[TBL] [Abstract][Full Text] [Related]
9. One-year monkey heart xenograft survival in cyclosporine-treated baboons. Suppression of the xenoantibody response with total-lymphoid irradiation.
Roslin MS; Tranbaugh RE; Panza A; Coons MS; Kim YD; Chang T; Cunningham JN; Norin AJ
Transplantation; 1992 Dec; 54(6):949-55. PubMed ID: 1465788
[TBL] [Abstract][Full Text] [Related]
10. Treatment with a short course of LF 15-0195 and continuous cyclosporin A attenuates acute xenograft rejection in a rat-to-mouse cardiac transplantation model.
Wang H; Hosiawa KA; Garcia B; Shum JB; Dutartre P; Kelvin DJ; Zhong R
Xenotransplantation; 2003 Jul; 10(4):325-36. PubMed ID: 12795681
[TBL] [Abstract][Full Text] [Related]
11. Prolongation of primate cardiac allograft survival by treatment with ANTI-CD40 ligand (CD154) antibody.
Pierson RN; Chang AC; Blum MG; Blair KS; Scott MA; Atkinson JB; Collins BJ; Zhang JP; Thomas DW; Burkly LC; Miller GG
Transplantation; 1999 Dec; 68(11):1800-5. PubMed ID: 10609959
[TBL] [Abstract][Full Text] [Related]
12. Preemptive CD20+ B cell Depletion Attenuates Cardiac Allograft Vasculopathy in CD154-Treated Monkeys.
Azimzadeh AM; Zhang T; Wu G; Kelishadi SS; Stoddard T; OʼNeill N; Nguyen BN; Welty E; Avon C; Higuchi M; Mitchell SL; Hershfeld A; Cheng XF; Kronfli A; Rybak E; Burdorf L; Pierson RN
Transplantation; 2017 Jan; 101(1):63-73. PubMed ID: 27362307
[TBL] [Abstract][Full Text] [Related]
13. Selective CD28 Inhibition Modulates Alloimmunity and Cardiac Allograft Vasculopathy in Anti-CD154-Treated Monkeys.
Zhang T; Azimzadeh AM; Sun W; O'Neill NA; Sievert E; Bergbower E; Braileanu G; Burdorf L; Cheng X; Monahan T; Dahi S; Harris DG; Rybak E; Welty E; Kronfli A; Avon C; Pierson RN
Transplantation; 2018 Mar; 102(3):e90-e100. PubMed ID: 29319621
[TBL] [Abstract][Full Text] [Related]
14. TNX-1500, a crystallizable fragment-modified anti-CD154 antibody, prolongs nonhuman primate cardiac allograft survival.
Miura S; Habibabady ZA; Pollok F; Ma M; Rosales IA; Kinoshita K; Pratts S; McGrath G; Chaban R; Fogarty S; Meibohm B; Daugherty B; Lederman S; Pierson RN
Am J Transplant; 2023 Aug; 23(8):1182-1193. PubMed ID: 37030662
[TBL] [Abstract][Full Text] [Related]
15. Blockade of CD40-CD154 at the time of donor-specific blood transfusion does not lead to prolonged kidney allograft survival in nonhuman primates.
Ringers J; Haanstra KG; Kroczek RA; Kliem K; Kuhn EM; Wubben J; Ossevoort MA; Volk HD; Jonker M
Transplantation; 2002 Mar; 73(6):862-6. PubMed ID: 11923684
[TBL] [Abstract][Full Text] [Related]
16. Accelerated graft arteriosclerosis in cardiac transplants: complement activation promotes progression of lesions from medium to large arteries.
Qian Z; Hu W; Liu J; Sanfilippo F; Hruban RH; Baldwin WM
Transplantation; 2001 Sep; 72(5):900-6. PubMed ID: 11571457
[TBL] [Abstract][Full Text] [Related]
17. Co-stimulation blockade targeting CD154 and CD28/B7 modulates the induced antibody response after a pig-to-baboon cardiac xenograft.
Wu G; Pfeiffer S; Schröder C; Zhang T; Nguyen BN; Lea W; Kelishadi S; Atkinson JB; Schuurman HJ; White DJ; Azimzadeh AM; Pierson RN
Xenotransplantation; 2005 May; 12(3):197-208. PubMed ID: 15807770
[TBL] [Abstract][Full Text] [Related]
18. Prevention of acute vascular rejection by a functionally blocking anti-C5 monoclonal antibody combined with cyclosporine.
Wang H; Jiang J; Liu W; Kubelik D; Chen G; Gies D; Garcia B; Zhong R; Rother RP
Transplantation; 2005 May; 79(9):1121-7. PubMed ID: 15880054
[TBL] [Abstract][Full Text] [Related]
19. Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantation.
Montgomery SP; Xu H; Tadaki DK; Celniker A; Burkly LC; Berning JD; Cruzata F; Elster EA; Gray G; Kampen RL; Swanson SJ; Harlan DM; Kirk AD
Transplantation; 2002 Nov; 74(10):1365-9. PubMed ID: 12451232
[TBL] [Abstract][Full Text] [Related]
20. Fc-Silent Anti-CD154 Domain Antibody Effectively Prevents Nonhuman Primate Renal Allograft Rejection.
Kim SC; Wakwe W; Higginbotham LB; Mathews DV; Breeden CP; Stephenson AC; Jenkins J; Strobert E; Price K; Price L; Kuhn R; Wang H; Yamniuk A; Suchard S; Farris AB; Pearson TC; Larsen CP; Ford ML; Suri A; Nadler S; Adams AB
Am J Transplant; 2017 May; 17(5):1182-1192. PubMed ID: 28097811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
